Skip to content

Tenofovir crisis appeal by European activists

STIs: more questions than answers

ddI capsules: why the new dosing advice?

Hep C limits immune recovery on HAART

How good are new CD4 cells on HAART?

Latest News from ICAAC

Resistance to ddI and d4T may be underestimated

Are you being treated well?

Most people with Hep C not developing liver toxicity on HAART